Analysis of Host Responses to Mycobacterium tuberculosis Antigens in a Multi-Site Study of Subjects with Different TB and HIV Infection States in Sub-Saharan Africa

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Sutherland, Jayne S ^a   Lalor, Maeve K ^b   Black, Gillian F ^c   Ambrose, Lyn R ^d   Loxton, Andre G ^c   Chegou, Novel N ^c   Kassa, Desta ^e   Mihret, Adane ^f   Howe, Rawleigh ^f   Mayanja Kizza, Harriet ^g   Gomez, Marie P ^a   Donkor, Simon ^a   Franken, Kees ^h   Hanekom, Willem ⁱ   Klein, Michel R ^h   Parida, Shreemanta K ^j   Boom, W Henry ^k   Thiel, Bonnie A ^k   Crampin, Amelia C ^b,d   Ota, Martin ^a   Walzl, Gerhard ^c   Ottenhoff, Tom H M ^h   Dockrell, Hazel M ^b   Kaufmann, Stefan H E ^j   more..

^a Vaccinology Theme   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d KARONGA PREVENTION STUDY   (Malawi)

^e ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^f ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^g MAKERERE UNIVERSITY   (Uganda)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

^j MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^k FUNDACIÓ INSTITUT D INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AG85B ANTIGEN; BACTERIAL PROTEIN; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; HYBRID PROTEIN; LATENCY ANTIGEN; MYCOBACTERIUM ANTIGEN; REACTIVATION PROTEIN; RESUSCITATION PROMOTING FACTOR; RV0569 ANTIGEN; RV0867 ANTIGEN; RV1733 ANTIGEN; RV1735 ANTIGEN; RV1737 ANTIGEN; RV2029 ANTIGEN; SECRETED ANTIGEN; STARVATION INDUCED ANTIGEN; TB10.3 ANTIGEN; TB10.4 ANTIGEN; TUBERCULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL GENETICS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ETHIOPIA; GAMBIA; GEOGRAPHIC DISTRIBUTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MALAWI; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RESUSCITATION; SOUTH AFRICA; TUBERCULOSIS; UGANDA;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTIGENS, BACTERIAL; CD4 LYMPHOCYTE COUNT; CLUSTER ANALYSIS; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; YOUNG ADULT;

EID: 84883793385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074080     Document Type: Article

References (23)

1. Ernst JD, (2012) The immunological life cycle of tuberculosis. Nat Rev Immunol 12: 581-591. doi:10.1038/nri3259. PubMed: 22790178.
2. World Health Organization (2012) Global Tuberculosis Report 2012: WHO fact sheet number 104. Available: http://www.who.int/tb/publications/factsheet_global.pdf.
3. Ottenhoff TH, (2012) New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol 20: 419-428. doi:10.1016/j.tim.2012.06.002. PubMed: 22784857.
4. Ottenhoff TH, Kaufmann SH, (2012) Vaccines against tuberculosis: where are we and where do we need to go? PLOS Pathog 8: e1002607.
5. Leistikow RL, Morton RA, Bartek IL, Frimpong I, Wagner K, et al. (2010) The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from non-respiring dormancy. J Bacteriol 192: 1662-1670. doi:10.1128/JB.00926-09. PubMed: 20023019.
6. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO, (2009) Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 39: 723-729. doi:10.1002/eji.200838693. PubMed: 19224636.
7. Caccamo N, Guggino G, Joosten SA, Gelsomino G, Di Carlo P, et al. (2010) Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 40: 2211-2220. doi:10.1002/eji.201040455. PubMed: 20540114.
8. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, et al. (2013) Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381: 1021-1028. doi:10.1016/S0140-6736(13)60177-4. PubMed: 23391465.
9. Odutola AA, Owolabi OA, Owiafe PK, McShane H, Ota MO, (2012) A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants. Vaccine 30: 5591-5594. doi:10.1016/j.vaccine.2012.06.054. PubMed: 22749600.
10. Black GF, Thiel BA, Ota MO, Parida SK, Adegbola R, et al. (2009) Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol 16: 1203-1212. doi:10.1128/CVI.00111-09. PubMed: 19553548.
11. Chegou NN, Essone PN, Loxton AG, Stanley K, Black GF, et al. (2012) Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area. PLOS ONE 7: e38501. doi:10.1371/journal.pone.0038501. PubMed: 22693640.
12. Leyten EM, Lin MY, Franken KL, Friggen AH, Prins C, et al. (2006) Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect 8: 2052-2060. doi:10.1016/j.micinf.2006.03.018. PubMed: 16931093.
13. Ottenhoff TH, Ellner JJ, Kaufmann SH, (2012) Ten challenges for TB biomarkers. Tuberculosis (Edinb) 92: S17-S20. doi:10.1016/S1472-9792(12)70007-0. PubMed: 22441153.
14. Black GF, Fine PEM, Warndorff DK, Floyd S, Weir RE, et al. (2001) Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int J Tuberc Lung Dis 5: 664-672. PubMed: 11467373.
15. de Jong BC, Hill PC, Aiken A, Awine T, Antonio M, et al. (2008) Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 198: 1037-1043. doi:10.1086/591504. PubMed: 18702608.
16. Phong WY, Lin W, Rao SP, Dick T, Alonso S, et al. (2013) Characterization of Phosphofructokinase Activity in Mycobacterium tuberculosis Reveals That a Functional Glycolytic Carbon Flow Is Necessary to Limit the Accumulation of Toxic Metabolic Intermediates under Hypoxia. PLOS ONE 8: e56037. doi:10.1371/journal.pone.0056037. PubMed: 23409118.
17. Macdonald SH, Woodward E, Coleman MM, Dorris ER, Nadarajan P, et al. (2012) Networked T cell death following macrophage infection by Mycobacterium tuberculosis. PLOS ONE 7: e38488. doi:10.1371/journal.pone.0038488. PubMed: 22675566.
18. Inokuchi N, Sugahara K, Soda H, Usui T, Hirakata Y, et al. (2003) Relationship between whole-blood interferon-gamma production and extent of radiographic disease in patients with pulmonary tuberculosis. Diagn Microbiol Infect Dis 46: 109-114. doi:10.1016/S0732-8893(03)00018-X. PubMed: 12812714.
19. Santema W, Rutten V, Segers R, Poot J, Hensen S, et al. (2013) Post-exposure subunit vaccination against chronic enteric mycobacterial infection in a natural host. Infect Immun 81: 1990-1995. doi:10.1128/IAI.01121-12. PubMed: 23509147.
20. Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, et al. (2010) Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 42: 498-503. doi:10.1038/ng.590. PubMed: 20495566.
21. Lindestam Arlehamn CS, Gerasimova A, Mele F, Henderson R, Swann J, et al. (2013) Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset. PLOS Pathog 9: e1003130.
22. Commandeur S, van Meijgaarden KE, Prins C, Pichugin AV, Dijkman K, et al. (2013) An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection. J Immunol 190: 1659-1671. doi:10.4049/jimmunol.1201593. PubMed: 23319735.
23. Goldsack L, Kirman JR, (2007) Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis. Tuberculosis (Edinb) 87: 465-473. doi:10.1016/j.tube.2007.07.001.